![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Maithri Drugs Private Limited Bonthapally Village In, based in India, is a pharmaceutical company.
One of their significant offerings is Mirtazapine, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2017-010 - Rev 01
This Chemical Type CEP, issued on June 17, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2338 associated with this CEP further emphasizes